Envoy Medical Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | +5.6% | +77.3% | +30.1% | +74.6% | |
| – | – | – | -64.3% | -84.3% | |
| – | +311.6% | – | – | – | |
| – | – | – | – | – | |
| – | +74.4% | -29.8% | +540.5% | -81.7% | |
| – | +74.4% | -29.8% | +540.5% | -81.7% | |
| – | – | – | – | -25.7% | |
| – | – | – | – | +192.1% | |
| – | +0.0% | +18.0% | +102.2% | -51.9% | |
| – | +0.4% | +163.0% | -5.1% | -17.7% | |
| – | -96.6% | +12,070.1% | -68.6% | -237.9% | |
| – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.